ALPHA TEKNOVA, INC. Capital Expenditures
ALPHA TEKNOVA, INC. (TKNO) reported Capital Expenditures of $346.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-06
- ALPHA TEKNOVA, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $125.00K, a 39.61% decline year-over-year.
- ALPHA TEKNOVA, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $221.00K, a 7.28% increase year-over-year.
- ALPHA TEKNOVA, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $348.00K, a 38.62% decline year-over-year.
- ALPHA TEKNOVA, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $387.00K, a 16.92% increase year-over-year.
- ALPHA TEKNOVA, INC. payments to acquire property, plant, and equipment for fiscal 2025 was $1.15M, a 2.04% increase from fiscal 2024.
- ALPHA TEKNOVA, INC. payments to acquire property, plant, and equipment for fiscal 2024 was $1.13M, a 85.82% decline from fiscal 2023.
- ALPHA TEKNOVA, INC. payments to acquire property, plant, and equipment for fiscal 2023 was $7.93M, a 71.81% decline from fiscal 2022.
- ALPHA TEKNOVA, INC. payments to acquire property, plant, and equipment for fiscal 2022 was $28.15M, a 41.62% increase from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $125.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $346.00K 10-Q · filed 2026-08-06 | $694.00K derived: sum of 3 quarters · filed 2026-08-06 | $1.08M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $221.00K 10-Q · filed 2026-05-07 | $569.00K derived: sum of 2 quarters · filed 2026-05-07 | $956.00K derived: sum of 3 quarters · filed 2026-05-07 | $1.16M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $348.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $735.00K derived: sum of 2 quarters · filed 2026-03-02 | $942.00K derived: sum of 3 quarters · filed 2026-08-06 | $1.15M 10-K · filed 2026-03-02 |
| 2025-09-30 | $387.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $594.00K derived: sum of 2 quarters · filed 2026-08-06 | $800.00K 10-Q · filed 2025-11-07 | $1.37M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $207.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $413.00K 10-Q · filed 2026-08-06 | $980.00K derived: sum of 3 quarters · filed 2026-08-06 | $1.31M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $206.00K 10-Q · filed 2026-05-07 | $773.00K derived: sum of 2 quarters · filed 2026-05-07 | $1.10M derived: sum of 3 quarters · filed 2026-05-07 | $1.22M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $567.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $898.00K derived: sum of 2 quarters · filed 2026-03-02 | $1.01M derived: sum of 3 quarters · filed 2026-03-02 | $1.13M 10-K · filed 2026-03-02 |
| 2024-09-30 | $331.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $446.00K derived: sum of 2 quarters · filed 2025-11-07 | $558.00K 10-Q · filed 2025-11-07 | $870.00K derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-06-30 | $115.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $227.00K 10-Q · filed 2025-08-08 | $539.00K derived: sum of 3 quarters · filed 2025-08-08 | $1.51M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | $112.00K 10-Q · filed 2025-05-09 | $424.00K derived: sum of 2 quarters · filed 2025-05-09 | $1.40M derived: sum of 3 quarters · filed 2025-05-09 | $3.73M derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | $312.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $1.28M derived: sum of 2 quarters · filed 2025-03-07 | $3.62M derived: sum of 3 quarters · filed 2025-03-07 | $7.93M 10-K · filed 2025-03-07 |
| 2023-09-30 | $972.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $3.31M derived: sum of 2 quarters · filed 2024-11-08 | $7.62M 10-Q · filed 2024-11-08 | $12.35M derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $2.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $6.65M 10-Q · filed 2024-08-13 | $11.38M derived: sum of 3 quarters · filed 2024-08-13 | $17.96M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $4.31M 10-Q · filed 2024-05-13 | $9.04M derived: sum of 2 quarters · filed 2024-05-13 | $15.62M derived: sum of 3 quarters · filed 2024-05-13 | $26.54M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $4.73M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $11.31M derived: sum of 2 quarters · filed 2024-03-27 | $22.23M derived: sum of 3 quarters · filed 2024-03-27 | $28.15M 10-K · filed 2024-03-27 |
| 2022-09-30 | $6.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $17.50M derived: sum of 2 quarters · filed 2023-11-13 | $23.42M 10-Q · filed 2023-11-13 | $30.83M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $10.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $16.84M 10-Q · filed 2023-08-11 | $24.25M derived: sum of 3 quarters · filed 2023-08-11 | $28.16M derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $5.92M 10-Q · filed 2023-05-11 | $13.33M derived: sum of 2 quarters · filed 2023-05-11 | $17.24M derived: sum of 3 quarters · filed 2023-05-11 | $21.91M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $7.41M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $11.32M derived: sum of 2 quarters · filed 2023-03-30 | $15.99M derived: sum of 3 quarters · filed 2023-03-30 | $19.88M 10-K · filed 2023-03-30 |
| 2021-09-30 | $3.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $8.58M derived: sum of 2 quarters · filed 2022-11-14 | $12.46M 10-Q · filed 2022-11-14 | $15.96M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $4.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $8.56M 10-Q · filed 2022-08-11 | $12.05M derived: sum of 3 quarters · filed 2022-08-11 | $13.07M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $3.88M 10-Q · filed 2022-05-12 | $7.38M derived: sum of 2 quarters · filed 2022-05-12 | $8.40M derived: sum of 3 quarters · filed 2022-05-12 | |
| 2020-12-31 | $3.50M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-18 | $4.51M derived: sum of 2 quarters · filed 2022-03-18 | $5.47M 10-K · filed 2022-03-18 | |
| 2020-09-30 | $1.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $1.97M 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | $953.00K 10-Q · filed 2021-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |